Your browser doesn't support javascript.
loading
Prevalence and risk factors for high-risk human papillomavirus infection among women from three southern geopolitical zones of Nigeria.
Onwuamah, Chika Kingsley; Feng, Ning; Momoh, Abidemi Esther; Uwandu, Mabel; Ahmed, Rahaman Ademolu; Idigbe, Ifeoma; Vincent, Grace Deborah; Ogbu, Chinenye Angela; Okonkwo, Nkem; Sokei, Judith; Abimbola, Bowofoluwa Sharon; Ojopagogo, Temiloluwa; Okoli, Leona Chika; Adesina, Mary; Ezemelue, Priscilla Ngozi; Sowunmi, Omowunmi; Okwuzu, Jane; Labo Popoola, Olaoniye Habeebat; Shaibu, Joseph Ojonugwa; Ohihoin, Greg Aigbe; Nzeribe, Emily; David, Agatha; Olaleye, Olufemi; Ofotokun, Ighovwerha; Dong, Xiao Ping; Ezechi, Oliver Chukwujekwu.
Afiliação
  • Onwuamah CK; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Feng N; Center for Global Public Health, Chinese Centre for Disease Control and Prevention, Beijing, China.
  • Momoh AE; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Uwandu M; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Ahmed RA; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Idigbe I; Division of Allergy and Clinical Immunology, Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • Vincent GD; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria.
  • Ogbu CA; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Okonkwo N; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Sokei J; Department of Obstetrics and Gynaecology, Delta State University Teaching Hospital, Oghara, Delta, Nigeria.
  • Abimbola BS; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Ojopagogo T; Department of Pediatric Oncology (Hematology), Washington University in St. Louis, St. Louis, MO, United States.
  • Okoli LC; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Adesina M; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Ezemelue PN; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Sowunmi O; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Okwuzu J; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria.
  • Labo Popoola OH; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Shaibu JO; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria.
  • Ohihoin GA; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Nzeribe E; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • David A; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria.
  • Olaleye O; Department of Obstetrics and Gynaecology, Federal Medical Centre, Owerri, Imo, Nigeria.
  • Ofotokun I; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria.
  • Dong XP; Screening Section, Optimal Cancer Care Foundation Centre, Lagos, Nigeria.
  • Ezechi OC; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
Front Oncol ; 13: 1254304, 2023.
Article em En | MEDLINE | ID: mdl-37876969
ABSTRACT

Introduction:

Human Papillomavirus (HPV) infection is a risk factor for cervical cancer, the fourth most common cancer among women globally. Its burden is the highest in sub-Saharan Africa, with over 90% mortality. Interventions may fail without evidence-based data on stratified prevalence and risk factors among most at-risk women across Nigeria.

Methods:

A cross-sectional comparative study, with participants recruited from the Nigerian Institute of Medical Research's Clinics, NGO outreaches, a cancer screening centre and a university teaching hospital. Questionnaires were self-administered. Trained medics performed sampling at healthcare facilities, and self-sampling was used at outreaches.

Results:

Nine hundred eighty-five study participants were recruited. About 37% and 27% of the women knew about HPV and its vaccines, respectively, but only 6% confirmed vaccination with HPV vaccines. HPV prevalence was highest among women with unknown marital status (35.9%), single women (33.8%), widowed/divorced/separated women (30.3%), and married/cohabiting women (19.6%). HPV infection was significantly higher among women who take alcohol (odds=1.7 [95% CI 1.2-2.4]) and women who smoke (odds=2.6 [95% CI 1.4 - 4.6]. HPV strains detected included HPV16 (1.3%), HPV18 (1.5%), Low Risk (0.2%) and Other High-Risk groups (19.7%).

Conclusion:

The inverse relationship between prevalence and education suggests interventions improving awareness and prevention would be impactful. Such interventions could also target HIV-positive women, women presenting with sexually-transmitted infections, who smoke and frequently drink alcohol.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nigéria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Nigéria